Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 1,228,065 |
|
|||||
| News | - | ||||||
| Day High | 3.00 | Low High |
|||||
| Day Low | 2.565 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Elevation Oncology Inc | ELEV | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.215 | -7.23% | 2.76 | 23:00:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.00 | 2.565 | 3.00 | 2.76 | 2.975 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,368 | 1,228,065 | US$ 2.77 | US$ 3,399,342 | - | 0.363 - 5.8299 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:15:38 | 65 | US$ 2.75 | USD |
Elevation Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 134.76M | 48.65M | - | 0 | -45.7M | -0.94 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Elevation Oncology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELEV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.56 | 3.595 | 2.565 | 3.25 | 418,266 | -0.80 | -22.47% |
| 1 Month | 3.73 | 4.33 | 2.565 | 3.65 | 413,065 | -0.97 | -26.01% |
| 3 Months | 4.59 | 5.8299 | 2.565 | 4.18 | 684,202 | -1.83 | -39.87% |
| 6 Months | 0.5192 | 5.8299 | 0.4401 | 2.75 | 1,840,852 | 2.24 | 431.59% |
| 1 Year | 1.45 | 5.8299 | 0.363 | 2.53 | 1,036,138 | 1.31 | 90.34% |
| 3 Years | 14.00 | 16.22 | 0.363 | 3.08 | 630,674 | -11.24 | -80.29% |
| 5 Years | 14.00 | 16.22 | 0.363 | 3.08 | 630,674 | -11.24 | -80.29% |
Elevation Oncology Description
| Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. |
